Early developmental lead exposure increases sensitivity to cocaine in a self-administration paradigm

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 1, 2004, Pages 127-135

  Nation, Jack R ^a   Smith, Kelly R ^b   Bratton, Gerald R ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Addiction; Cocaine; Developmental; Lead; Self administration

Indexed keywords

COCAINE; LEAD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREEDING METHOD; CHEMOSENSITIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG SELF ADMINISTRATION; EXPOSURE; FEEDING; LACTATION; LIFE CYCLE; MALE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; WEANING;

ANIMALIA;

EID: 0347915542     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.10.009     Document Type: Article

References (45)

1. Brody D.J., Pirkle J.L., Kramer R.A., Flegal K.M., Matte T.D., Gunter E.W.et al. Blood lead levels in the US population: Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1991). JAMA. 272:1994;277-283.
2. Burkey R.T., Nation J.R., Grover C.A., Bratton G.R. Effects of chronic lead exposure on cocaine-induced disturbance of fixed-interval behavior. Pharmacol. Biochem. Behav. 56:1997;117-121.
3. Caine S.B., Negus S.S., Mello N.K. Effects of dopamine D1-like and D2-like agonists on cocaine self-administration in rhesus monkeys: rapid assessments of cocaine dose-effect functions. Psychopharmacology. 148:2000;41-51.
4. Campbell U.C., Lac S.T., Carroll M.E. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology. 143:1999;209-214.
5. Cornish J.L., Duffy P., Kalivas P.W. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience. 93:1999;1359-1367.
6. Cuomo V., De Salvia M.A., Petruzzi S., Alleva E. Appropriate end points for the characterization of behavioral changes in developmental toxicology. Environ. Health Perspect. 104:1996;307-315.
7. Dearth R.K., Hiney J.K., Srivasta V.K., Burdick S.B., Bratton G.R., Dees W.L. Effects of lead (Pb) exposure during gestation and lactation on female pubertal development in the rat. Reprod. Toxicol. 16:2003;343-352.
8. Ensminger M.E., Anthony J.C., McCord J. The inner city and drug use: initial findings from an epidemiological study. Drug Alcohol Depend. 48:1997;175-184.
9. Goeders N.E. A neuroendocrine role in cocaine reinforcement. Neuroendocrinology. 22:1997;237-259.
10. Harwell T.S., Spence M.R., Sands A., Iguchi M.Y. Substance use in an inner-city family planning population. J. Reprod. Med. 41:1996;704-710.
11. Hemby S.E., Co C., Koves T.R., Smith J.E., Dworkin S.I. Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology. 133:1997;7-16.
12. Ho B.T., Taylor D.L., Estevez V.S., Englert L.F., McKenna M.L. Behavioral effects of cocaine: a metabolic and neurochemical approach. Ellinwood E.H. Jr., Kilby M.M. Cocaine and other stimulants. Advances in behavioral biology. vol. 21:1977;229-240 Plenum, New York.
13. Holson R.R., Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol. Teratol. 14:1992;221-228.
14. Hooks M.S., Duffy P., Striplin C., Kalivas P.W. Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacology. 115:1994;265-272.
15. Kalivas P.W. Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend. 37:1995;95-100.
16. Kalivas P.W. Neural basis of cocaine sensitization to cocaine. Hammer R.P. The neurobiology of cocaine: cellular and molecular mechanisms. 1995;81-98 CRC Press, Boca Raton (FL).
17. Lasley S.M., Gilbert M.E. Presynaptic glutamatergic function in dentate gyrus in vivo is diminished by chronic exposure to inorganic lead. Brain Res. 736:1996;125-134.
18. Lasley S.M., Green M.C., Gilbert M.E. Influence of exposure period on in vivo hippocampal glutamate and GABA release in rats. Neurotoxicology. 20:1999;619-629.
19. Lasley S.M., Green M.C., Gilbert M.E. Rat hippocampal NMDA receptor binding as a function of chronic lead exposure level. Neurotoxicol. Teratol. 23:2001;185-189.
20. Lynch W.J., Carroll M.E. Regulation of drug intake. Exp. Clin. Psychopharmacol. 9:2001;131-143.
21. McFarland K., Kalivas P.W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 21:2001;8655-8663.
22. Mielke H.W. Lead in the inner cities. Am. Sci. 87:1999;62-73.
23. Miller D.K., Nation J.R., Bratton G.R. Perinatal exposure to lead attenuates the conditioned reinforcing properties of cocaine in male rats. Pharmacol. Biochem. Behav. 67:2000;111-119.
24. Miller D.K., Nation J.R., Bratton G.R. The effects of perinatal exposure to lead on the discriminative properties of cocaine and related drugs. Psychopharmacology. 158:2001;165-174.
25. Moreira E.G., Rosa G., Barros S.B., Vassilieff V.S., Vassillieff I. Antioxidant defense in rat brain regions after developmental lead exposure. Toxicology. 169:2001;145-151.
26. Nation J.R., Livermore C.L., Burkey R.T. Chronic lead exposure attenuates sensitization to the locomotor-stimulating effects of cocaine. Drug Alcohol Depend. 41:1996;143-149.
27. Nation J.R., Wellman P.J., Livermore C.L., Miller D.K., Bratton G.R. Brain and plasma levels of cocaine and benzoylecgonine in lead-exposed and cadmium-exposed rats following acute or chronic intraperitoneal administration of cocaine. Toxicol. Lett. 92:1997;47-57.
28. Nation J.R., Miller D.K., Bratton G.R. Perinatal lead exposure alters the stimulatory properties of cocaine at PND 30 and PND 90 in the rat. Neuropsychopharmacology. 23:2000;444-454.
29. Nation J.R., Cardon A.L., Heard H.M., Valles R., Bratton G.R. Perinatal lead exposure and relapse to drug-seeking behavior in the rat: a cocaine reinstatement study. Psychopharmacology. 168:2003;236-243.
30. 3H]cocaine in acutely and chronically treated rats. J. Pharmacol. Exp. Ther. 196:1976;556-569.
31. Pan H., Menacherry S., Justice J.B. Differences in pharmacokinetics of cocaine in naïve and cocaine-experienced rats. Neurochemistry. 56:1991;1299-1306.
32. Phillips A.G., Di Ciano P. Behavioral sensitization is induced by intravenous self-administration of cocaine by rats. Psychopharmacology. 124:1996;279-281.
33. Pirkle J.L., Kaufmann R.B., Brody D.J., Hickman T., Gunter E.W., Paschal D.C. Exposure of the U.S. population to lead, 1991-1994. Environ. Health Perspect. 106:1998;745-750.
34. Pokora M.J., Richfield E.K., Cory-Slechta D.A. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments. J. Neurochem. 67:1996;1540-1550.
35. Ranaldi R., Wise R.A. Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine. J. Neurosci. 21:2001;5841-5846.
36. Reith M.E.A., Benuck M., Lajtha A. Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J. Pharmacol. Exp. Ther. 243:1987;281-287.
37. Roberts D.C., Brebner K. New medications for drug abuse. Ann. NY Acad. Sci. 909:2000;145-158.
38. Schenk S., Partridge B. Sensitization to cocaine's reinforcing effects produced by various cocaine pretreatment regimens in rats. Pharmacol. Biochem. Behav. 66:2000;765-770.
39. See R.E., Kruzich P.J., Grimm J.W. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology. 154:2001;301-310.
40. Smith S.S. Withdrawal properties of a neuroactive steroid: implications for GABA(A) receptor gene regulation in the brain and anxiety behavior. Steroids. 67:2002;519-528.
41. Tavakoli-Nezhad M., Barron A.J., Pitts D.K. Postnatal inorganic lead exposure decreases the number of spontaneously active midbrain dopamine neurons in the rat. Neurotoxicology. 22:2001;259-269.
42. Trujillo K.A., Akil H. Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend. 38:1995;139-154.
43. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;445-460.
44. Wise R.A., Newton P., Leeb K., Burnette B., Pocock D., Justice J. Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacologia. 120:1995;10-20.
45. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.